RADX vs GRCE
Comparison between Radiopharm Theranostics Ltd (RADX, Company) and Acasti Pharma Inc (GRCE, Company).
Both RADX and GRCE are from the Healthcare sector.
RADX vs GRCE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
RADX
$36M
GRCE
$36M
Max Drawdown
RADX
79.68%
Winner
GRCE
60.00%
Sharpe Ratio
Winner
RADX
0.45
GRCE
0.07
5Y Beta
Winner
RADX
0.44
GRCE
0.90
Industry
RADX
Biotechnology
GRCE
Biotechnology
P/E Ratio
RADX
N/A
GRCE
-5.64
Forward P/E
RADX
N/A
GRCE
2.17
Debt to Equity
RADX
N/A
GRCE
0.00%
Free Cash Flow Yield
RADX
N/A
GRCE
-28.09%
P/S Ratio
Winner
RADX
2.22
GRCE
197.75
P/B Ratio
RADX
1.13
Winner
GRCE
0.61
RADX vs GRCE - Historical Returns
Returns include dividend reinvestment.
1M
RADX
-5.88%
Winner
GRCE
-1.29%
3M
Winner
RADX
-7.49%
GRCE
-38.83%
6M
Winner
RADX
-9.05%
GRCE
-28.57%
1Y
Winner
RADX
-9.83%
GRCE
-22.30%
Max(CAGR)
RADX
-60.96%
Winner
GRCE
-15.16%
RADX vs GRCE - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | RADX | GRCE |
|---|---|---|
| 2026 | -16.28% | -37.16% |
| 2025 | +12.50% | -13.50% |
| 2024 | -74.59% | +23.84% |
RADX vs GRCE Drawdown Comparison
The maximum drawdown for RADX was -79.68%, occurring on Jul 7, 2025. This drawdown has not yet recovered.
The maximum drawdown for GRCE was -60.00%, occurring on Apr 7, 2025. Recovery took 323 trading sessions.
The current RADX drawdown is -77.14%. The current GRCE drawdown is -55.17%.
| Rank | RADX | GRCE |
|---|---|---|
| #1 | -79.68% Dec 6, 2024 - Jul 7, 2025 | -60.00% Dec 6, 2024 - Mar 25, 2026 |
| #2 | N/A | -59.06% Apr 2, 2026 - Apr 28, 2026 |
| #3 | N/A | -18.06% Oct 23, 2024 - Dec 4, 2024 |
| #4 | N/A | -8.60% Mar 26, 2026 - Apr 1, 2026 |
| #5 | N/A | -5.57% Oct 10, 2024 - Oct 23, 2024 |
Correlation
Correlation between RADX and GRCE is 0.17 which considered as a very weak or no correlation - the stocks move independently of each other.
0.17
-101
Select Stocks to Compare
Popular: RADX vs SPYGRCE vs SPY
More Comparisons
Compare with similar stocks